![f026-01.jpg](https://article-imgs.scribdassets.com/3tkzwck6psb6ynrt/images/fileRVBOLAUO.jpg)
“Denizens of Silicon Valley have long hailed microdoses of psychedelic drugs as a means of unlocking creativity” and improving mental health, says the Financial Times. Where tech leads, Wall Street often follows – and leading the charge is Steve Cohen. The veteran hedge-fund manager behind Point72 Asset Management, and his wife, are backing efforts to make mind-altering drugs such as MDMA,